India’s love for gold has done little for its economy and investors, BlackRock’s Larry Fink says
Fink emphasized the importance of capital markets and how they can improve a country’s economic standing as opposed to gold.
This small Southeast Asian country has ‘engineered’ a society that lives to 100 – here’s how
Singapore is the world’s sixth “blue zone,” successfully creating policy that promotes longevity for citizens, according to Dan Buettner who coined the term.
China opens WTO dispute against U.S. subsidies to protect its EV industry
China has initiated dispute settlement proceedings against the United States at the World Trade Organization to safeguard its interests in the EV industry.
CNBC Daily Open: U.S. consumers’ optimism wanes
U.S. consumer confidence appears to be waning as anxiety grows about the economy.
Asia stocks mixed as investors assess China, Australia economic data; yen falls to 34-year low
China’s combined industrial profit for January and February climbed 10.2% year on year, data showed. Industrial profits fell 2.3% for the whole of 2023.
Feds seek seizure of two New York apartments worth $14 million tied to former Mongolia leader in alleged mining scheme
Two luxury apartments in New York allegedly were bought with proceeds from improperly awarded copper contracts related to a huge mine in Mongolia.
Nvidia’s partners and more: BofA picks key global stocks along the AI supply chain
The investment bank named various parts of the supply chain that stand to benefit from artificial intelligence — and its top stocks in each category.
Want to invest $10,000? Here are 5 ETFs to buy now and hold, according to the pros
CNBC Pro asked finance experts for their top ETF picks to buy and hold this year.
Dow surges more than 450 points, S&P 500 closes at a fresh record: Live updates
Stocks rose Wednesday following a losing session on Wall Street that pulled the indexes further from record levels.
FDA approves Merck’s drug for rare, deadly lung condition
The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.
